COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate

(2021) M.C. Garassino et al.   ANNALS OF ONCOLOGY

COVID-19 vaccines for patients with cancer: benefits likely outweigh risks

(2021) Joyce K. Hwang et al.   Journal of Hematology & Oncology

Prevalence of Underlying Medical Conditions Associated With Severe COVID-19 Illness in Adult Cancer Survivors in the United States

(2021) Changchuan Jiang et al.   JNCI-Journal of the National Cancer Institute

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

(2021) Florian Krammer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis

(2021) Adam Booth et al.   PLoS One

Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines

(2021) Johanna Chapin-Bardales et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data

(2021) Robert H Shaw et al.   LANCET

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

(2021) Cristina Menni et al.   LANCET INFECTIOUS DISEASES

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

(2021) Barliz Waissengrin et al.   LANCET ONCOLOGY

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

(2021) Leticia Monin et al.   LANCET ONCOLOGY

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination

(2021) Nina H. Schultz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

(2021) Andreas Greinacher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study

(2021) David J. Pinato et al.   EUROPEAN JOURNAL OF CANCER

Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic

(2020) Amit Sud et al.   ANNALS OF ONCOLOGY

Guy’s cancer cohort – real world evidence for cancer pathways

(2020) C. Moss et al.   BMC CANCER

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

(2020) Camille Maringe et al.   LANCET ONCOLOGY

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

(2020) Edward E. Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

(2020) Maheshi N Ramasamy et al.   LANCET

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited

(2020) Antoni Ribas et al.   Cancer Discovery

The how’s and what’s of vaccine reactogenicity

(2019) Caroline Hervé et al.   npj Vaccines

Practical review of immunizations in adult patients with cancer

(2015) Ella J Ariza-Heredia et al.   Human Vaccines & Immunotherapeutics